Treatment with the PARP-inhibitor PJ34 causes enhanced...

Anti-Cancer Drugs 2012 / 07 Vol. 23; Iss. 6

Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells

Magan, Natisha, Isaacs, Richard J., Stowell, Kathryn M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0b013e328350900f
Date:
July, 2012
File:
PDF, 814 KB
english, 2012
Conversion to is in progress
Conversion to is failed